You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Enantioselective organocatalysis
|
|---|---|
| Published in |
Drug Discovery Today, November 2006
|
| DOI | 10.1016/j.drudis.2006.11.004 |
| Pubmed ID | |
| Authors |
Matthew J. Gaunt, Carin C.C. Johansson, Andy McNally, Ngoc T. Vo |
| Abstract |
Enantioselective organocatalysis has emerged as a powerful synthetic paradigm that is complementary to metal-catalysed transformations and has accelerated the development of new methods to make diverse chiral molecules. The operational simplicity, ready availability of catalysts and low toxicity associated with organocatalysis makes it an attractive method to synthesise complex structures. Here, we discuss the impact of enamine, iminium, nucleophilic and Brønsted acid catalysts in organic synthesis, and highlight key strategic methods to assemble useful molecules with high enantiomeric purity. |
Mendeley readers
The data shown below were compiled from readership statistics for 664 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | <1% |
| United Kingdom | 4 | <1% |
| Switzerland | 3 | <1% |
| India | 3 | <1% |
| Mexico | 2 | <1% |
| Poland | 2 | <1% |
| France | 2 | <1% |
| Italy | 2 | <1% |
| Australia | 1 | <1% |
| Other | 12 | 2% |
| Unknown | 628 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 194 | 29% |
| Student > Master | 102 | 15% |
| Researcher | 91 | 14% |
| Student > Bachelor | 78 | 12% |
| Student > Doctoral Student | 31 | 5% |
| Other | 104 | 16% |
| Unknown | 64 | 10% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 523 | 79% |
| Agricultural and Biological Sciences | 13 | 2% |
| Materials Science | 8 | 1% |
| Chemical Engineering | 8 | 1% |
| Biochemistry, Genetics and Molecular Biology | 7 | 1% |
| Other | 25 | 4% |
| Unknown | 80 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2022.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Drug Discovery Today
#1,370
of 2,885 outputs
Outputs of similar age
#44,667
of 168,271 outputs
Outputs of similar age from Drug Discovery Today
#11
of 18 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,885 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,271 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.